Profil
Mr. Kees J.
M.
Scholtes is Chairman-Supervisory Board at BinckBank NV and a Member-Executive Board at Colonnade Securities BV.
He is on the Board of Directors at Harbour Antibodies BV.
Mr. Scholtes was previously employed as Chairman-Supervisory Board by Ibus Asset Management BV, a Member-Executive Board by ING Bank NV, a Member-Executive Board by Postbank NV, a Member-Executive Committee by Amsterdam Stock Exchange, a Member-Executive Committee by European Options Exchange, a Member-Supervisory Board by Baring Private Equity Asia III Holding, a Member-Supervisory Board by Euroclear Nederland BV, and a Member-Supervisory Board by RBC Investor Services Ltd.
Anciens postes connus de Kees J. M. Scholtes
| Sociétés | Poste | Fin |
|---|---|---|
| BINCKBANK N.V. | Président | 30/04/2015 |
Harbour Antibodies BV
 Harbour Antibodies BV Medical/Nursing ServicesHealth Services Harbour Antibodies BV engages in the production of antibodies and VH domains for therapy. The firm develops two types of human immunoglobulin gene transgenic mice such as mice that generate conventional tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). The company was founded by Frank Grosveld in 2006 and is headquartered in Rotterdam, the Netherlands. | Directeur/Membre du Conseil | - |
| European Options Exchange | Corporate Officer/Principal | - |
| Amsterdam Stock Exchange | Corporate Officer/Principal | - |
RBC Investor Services Ltd.
 RBC Investor Services Ltd. Investment Banks/BrokersFinance RBC Investor Services Ltd. provided security dealing and flotation services. The company was founded in 2006 and was headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
| European Options Exchange | Finance |
| Amsterdam Stock Exchange | Finance |
ING Bank NV
 ING Bank NV Major BanksFinance ING Bank NV engages in the provision of banking, investment, life insurance, and retirement services. It operates through the following segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The Retail Netherlands segment offers current and savings accounts, business lending, mortgages, and other consumer lending in the Netherlands. The Retail Belgium segment focuses in the retail and private banking activities in Belgium and offered services like the Netherland segment. The Retail Germany segment consists of current and savings accounts, mortgages, and other customer lending. The Retail Other segment comprises income from retail banking activities in the rest of the world, including the SME and mid-corporate segments. The Wholesale Banking segment include income from wholesale banking activities (a full range of products is offered from cash management to corporate finance), real estate, and lease. The Corporate Line Banking segment comprises corporate line banking and the run-off portfolio of Real Estate. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Finance |
Colonnade Securities BV
 Colonnade Securities BV Financial ConglomeratesFinance Colonnade Securities BV provides loans to Dutch housing associations. The company is headquartered in Huizen, the Netherlands. | Finance |
Postbank NV
 Postbank NV Regional BanksFinance Part of ING Groep NV, Postbank NV is a large Dutch bank. The company is based in Amsterdam, Netherlands. A. van der Lugt. The Dutch company was founded by Godfried J. | Finance |
BinckBank NV
 BinckBank NV Investment Banks/BrokersFinance BinckBank NV engages in the provision of financial services. It offers services in investment, asset management, and savings. It operates through the following segments: Netherlands, Belgium, France, Italy, and Group Activities. The Netherlands segment includes asset management services and the issue of financial instruments. The Group Activities segment consists of expenses of the central information and communications technology, operations, and staff departments. The company was founded by Thierry C. V. Schaap in 2000 and is headquartered in Amsterdam, the Netherlands. | Finance |
Euroclear Nederland BV
 Euroclear Nederland BV Investment Banks/BrokersFinance Euroclear Nederland BV provides securities administration services. The firm offers real-time settlement, custody, and securities administration services for capital market paper and money market paper. The firm's services include securities settlement, safekeeping, corporate actions, income and redemptions, market claims management and new issues services. The company was founded in 1977 and is located in Amsterdam, The Netherlands. | Finance |
RBC Investor Services Ltd.
RBC Investor Services Ltd. Investment Banks/BrokersFinance RBC Investor Services Ltd. provided security dealing and flotation services. The company was founded in 2006 and was headquartered in London, the United Kingdom. | Finance |
Baring Private Equity Asia III Holding (2) B.V.
 Baring Private Equity Asia III Holding (2) B.V. Financial ConglomeratesFinance Part of EQT AB, Baring Private Equity Asia III Holding (2) B.V. provides investment management services. The company is based in Amsterdam, Netherlands. | Finance |
Ibus Asset Management BV
 Ibus Asset Management BV Real Estate DevelopmentFinance Ibus Asset Management BV operates as an independent, international real estate investment and asset management company. It offers asset management services for banks with REO portfolios and pension funds that outsource the real estate asset management. The company is headquartered in Amstelveen, the Netherlands. | Finance |
Harbour Antibodies BV
Harbour Antibodies BV Medical/Nursing ServicesHealth Services Harbour Antibodies BV engages in the production of antibodies and VH domains for therapy. The firm develops two types of human immunoglobulin gene transgenic mice such as mice that generate conventional tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). The company was founded by Frank Grosveld in 2006 and is headquartered in Rotterdam, the Netherlands. | Health Services |
